Rayence Co., Ltd. (228850) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Rayence Co., Ltd. (228850:KRX), powered by AI.

Current Price
₩6,710
P/E Ratio
-21.1
Market Cap
111.3B
Sector
Healthcare
What is the Rayence Co., Ltd. stock price forecast?

Rayence Co., Ltd. is currently trading at ₩6,710. View real-time AI analysis on Alpha Lenz.

What is Rayence Co., Ltd. insider trading activity?

View the latest insider trading data for Rayence Co., Ltd. on Alpha Lenz.

What is Rayence Co., Ltd.'s P/E ratio?

Rayence Co., Ltd.'s P/E ratio is -21.1.

Rayence Co., Ltd.

KRX · 228850
₩6,710-90(-1.32%)Market closedKRX regular session 09:00–15:30 KST
Ask about Rayence Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Rayence Co., Ltd. trades at a P/E of -21.1 (undervalued) with modest ROE of -2.2%.

Ask for details

Company Overview

Rayence Co., Ltd. specializes in the development and manufacture of digital X-ray imaging components and systems. The primary function of the company is to provide state-of-the-art radiographic solutions that enhance diagnostic capabilities across various medical fields. Rayence's product range includes flat panel detectors, radiography and fluoroscopy systems, which are integral in providing clear, precise imaging essential for accurate diagnosis and treatment planning. Operating predominantly in the healthcare sector, Rayence impacts medical institutions, hospitals, and clinics by offering cutting-edge imaging technology that also extends into dental, veterinary, and industrial applications. The company's innovative approach has led to the integration of advanced technologies like Artificial Intelligence to improve image processing and analysis. In the financial market, Rayence Co., Ltd. is recognized for its contributions to the medical equipment industry, which is an essential component of the global healthcare market. It plays a critical role in supporting medical professionals to deliver better patient outcomes through improved diagnostic tools. Headquartered in South Korea, Rayence continues to expand its international presence, addressing the growing demand for advanced medical imaging solutions.

CEO서재정
SectorHealthcare
IndustryMedical Devices
Employees228

Company Statistics

FY 2025

Profile

₩111,325,703,940Market Cap
₩114,722,998,840Revenue
16.59MShares Out
228Employees

Margins

35.67%Gross
6.04%EBITDA
-3.44%Operating
-3.21%Pre-Tax
-4.64%Net

Valuation

-21.08P/E
0.47P/B
0.97EV/Sales
9.95EV/EBITDA
16.21P/FCF

Growth (CAGR)

-7.96%Rev 3Yr
2.47%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-2.01%ROA
-2.19%ROE
-1.27%ROIC

Financial Health

₩47,524,117,040Cash & Cash Equivalents
₩-23,673,760,950Net Debt
10.05%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Rayence Co., Ltd. (ticker: 228850) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 228 employees. Market cap is $111.3B.

The current price is ₩6,710 with a P/E ratio of -21.08x and P/B of 0.47x.

ROE is -2.19% and operating margin is -3.44%. Annual revenue is $114.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Rayence Co., Ltd. (228850) Stock Forecast 2026 ₩6,710 — Price, Financials & Analyst Targets | Alpha Lenz